Markku M Miettinen (Markku Miettinen)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Renal Cell Carcinoma

Patient Reported

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer research : MCR

Cancer research communications

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Shadin Ahmed, Mary Frances Wedekind Malone, Jaydira Del Rivero, Margarita Raygada, Robin Lockridge, John W Glod, Crystal Flowers, B J Thomas, Donna B Bernstein, Oxana B Kapustina, Ashish Jain, Markku M Miettinen, Mark Raffeld, Liqiang Xi, Manoj Tyagi, Jung Kim, Kenneth D Aldape, Ashkan A Malayeri, Rosandra N Kaplan, Taryn M Allen, Christina A Vivelo, Abby B Sandler, Brigitte C Widemann, Karlyne M Reilly
Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants. Cancer research communications (2023)
Benjamin L Green, Lauren A Gamble, Laurence P Diggs, Darryl Nousome, Jesse C Patterson, Brian A Joughin, Billel Gasmi, Stephanie C Lux, Sarah G Samaranayake, Markku M Miettinen, Martha Quezado, Jonathan M Hernandez, Micheal B Yaffe, Jeremy Lee Davis
Early immune changes support signet ring cell dormancy in CDH1-driven hereditary diffuse gastric carcinogenesis. Molecular cancer research : MCR (2023)
Srivandana Akshintala, R Taylor Sundby, Donna B Bernstein, John W Glod, Rosandra N Kaplan, Marielle E Yohe, Andrea M Gross, Joanne Derdak, Haiyan Lei, Alexander Pan, Eva Dombi, Isabel Palacio-Yance, Kailey R Herrera, Markku M Miettinen, Helen X Chen, Seth M Steinberg, Lee J Helman, Leo Mascarenhas, Brigitte C Widemann, Fariba Navid, Jack F Shern, Christine M Heske
Phase I trial of ganitumab plus dasatinib to cotarget the insulin-like growth factor 1 receptor and Src family kinase YES in rhabdomyosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sakshi Tomar, Jingli Zhang, Manakamana Khanal, Jessica Hong, Abhilash Venugopalan, Qun Jiang, Manjistha Sengupta, Markku M Miettinen, Nan Li, Ira H Pastan, Mitchell Ho, Raffit Hassan
Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors. Molecular cancer therapeutics 21 (7) (2022)
John A Ligon, R Taylor Sundby, Mary Frances Wedekind Malone, Fernanda I Arnaldez, Jaydira Del Rivero, Lori S Wiener, Ramaprasad Srinivasan, Melissa Spencer, Amanda Carbonell, Haiyan Lei, Jack F Shern, Seth M Steinberg, William Douglas Figg, Cody J Peer, Sara M Zimmerman, Josquin Moraly, Xia Xu, Stephen Fox, King Chan, Michael I Barbato, Thorkell Andressen, Naomi Taylor, Karel Pacak, J Keith Killian, Eva Dombi, W Marston Linehan, Markku M Miettinen, Richard L Piekarz, Lee J Helman, Paul S Meltzer, Brigitte C Widemann, John W Glod
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-associated Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)